Budget problems are hurting HIV patients

Cash-strapped states are cutting back on a program that provides free medicine to people with HIV, leaving thousands of patients to wonder where their drugs will come from and stirring fears of a return to the days when an AIDS diagnosis meant certain death. At least 19 states have taken such steps as capping enrollment, dropping patients, instituting waiting lists, lowering the income ceiling for eligibility, and no longer covering certain drugs or tests. The AIDS Drug Assistance Program is funded by the federal and state governments and run by the states. It provides free drugs in all 50 states
Read More

Drug Lobby: The big winner in health care ‘reform’

Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama‘s health care law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain health coverage. To be sure, the law also levies taxes and imposes other costs on pharmaceutical companies, leaving its final impact on the industry’s bottom line uncertain. A recent analysis by Goldman Sachs, the Wall Street firm, suggests the overhaul could mean “a manageable hit” of tens of billions of dollars over the coming decade while bolstering
Read More